ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

TransThera Sciences (Nanjing), Inc. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
cholangiocarcinoma
cholangiocarcinoma, refractory/relapsed cholangiocarcinoma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832790
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.